Navidea Biopharmaceuticals, Inc.
NAVBDelisted Jan 16, 2024- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000810509
Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Navidea Biopharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 28 | 30 | +2 |
| Shares | 1.63M | 1.40M | −230.6K (−14.1%) |
| Value | $339.3K | $364.4K | +$25.1K (+7.4%) |
New holders (4)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 128,756 | $33.0K | 0.00% |
| FMR LLC | 1,000 | $260 | 0.00% |
| Country Trust Bank | 7 | $2 | 0.00% |
| Royal Bank of Canada | 1 | $0 | 0.00% |
Sold out (2)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| PDS Planning, Inc | 10,565 | $2.22K |
| HRT Financial LP | 12,614 | $2.00K |